Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... successfully treated with immunosuppressive drug regimens or allogeneic stem cell transplantation. However, 20-40% of patients are ineligible for ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  2. Clinical Trials Report for January 2016

    ... Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies ... has a Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated ...

    Page last updated 01/07/2016 - 10:57am.

  3. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

    ... one of two study arms; Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT), Arm 2: ... Cell Transplant Bone marrow or peripheral blood stem cell transplant. The specific transplant treatment regimen will be at the ...

    Clinical Trial last updated 04/28/2016 - 10:50am.

  4. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... conditions for which CD34+ selected, T-cell depleted allogeneic hematopoietic stem cell transplantation is indicated such as: AML in 1st remission - ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  5. Recurrent and Secondary MDS

    ... approaches, after medical treatments, and even after an allogeneic stem cell transplant . So, I think of recurrent MDS to mean progression or ...

    Interview last updated 10/24/2012 - 1:12pm.

  6. Allo HSCT Using RIC for Hematological Diseases

    ... regimen followed by a related or unrelated donor stem cell infusion. The primary objective is to evaluate rates of acute ... Blood Stem Cells On day 0, patients will receive an allogeneic transplant using PBSC which are CD34+ selected as the donor graft. ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  7. Clinical Trials Report for April 2014

    ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ... determine the incidence of grade II-IV acute GVHD following Allogeneic (allo) Hematopoeitic Cell Transplant (HCT) using post-transplant ...

    Page last updated 04/18/2014 - 3:36pm.

  8. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... and disease free survival of 85% to 100%, can be obtained in allogeneic blood or bone marrow stem cell transplantation using an human leukocyte antigen ( HLA ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  9. Treating Higher-Risk Myelodysplastic Syndromes

    ... cure, then the eventual goal or desired treatment is an allogeneic stem cell transplant . Depending on patient’s age and the stage or status ...

    Interview last updated 05/18/2012 - 1:55pm.

  10. Nurse's Corner Summer 2015: Understanding the Etiology and Epidemiology of Myelodysplastic Syndromes

    ... Syndromes (MDS) are a group of malignant hematopoietic stem cell diseases characterized by bone marrow failure , with resultant ... higher risk, the goal of treatment is to improve survival. Allogeneic hematopoietic stem cell transplant and hypomethyalting ...

    Page last updated 07/27/2015 - 12:04pm.